Increased mortality rates in young and middle-aged patients with malignant germ cell tumours

Cisplatin-based chemotherapy of malignant germ cell tumours (MGCT) has been reported to increase the risk of cardiovascular morbidity. A high incidence of second nongerm cell malignancies is well documented in MGCT survivors. The death risk due to these conditions is, however, more unknown in MGCT p...

Descripción completa

Detalles Bibliográficos
Autores principales: Fosså, S D, Aass, N, Harvei, S, Tretli, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409607/
https://www.ncbi.nlm.nih.gov/pubmed/14760372
http://dx.doi.org/10.1038/sj.bjc.6601558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409607/
https://www.ncbi.nlm.nih.gov/pubmed/14760372
http://dx.doi.org/10.1038/sj.bjc.6601558

Ejemplares similares